Huminsulin N 100IU/ml Cartridge contains Insulin Isophane, a suspension of intermediate-acting insulin used for the management of diabetes mellitus. This formulation provides basal insulin coverage, helping to control blood glucose levels between meals and overnight. Huminsulin N is indicated for patients requiring insulin therapy to achieve glycemic control when diet, exercise, and oral hypoglycemic agents alone are insufficient. The insulin isophane component has an onset of action typically within 1 to 2 hours, with peak activity occurring between 4 to 12 hours and a duration of action lasting approximately 18 to 24 hours. The cartridge is designed for use with compatible insulin pens, allowing for accurate dosing and convenient administration. Proper dose titration should be guided by regular monitoring of blood glucose levels to minimize the risk of hypoglycemia and hyperglycemia. Patients should be educated on injection techniques, storage conditions, and recognition of adverse effects such as hypoglycemia, allergic reactions, or lipodystrophy at the injection site. Huminsulin N should be used under medical supervision, with individualized dosing regimens tailored to the patient’s metabolic needs, lifestyle, and response to therapy to optimize diabetes management and reduce the risk of long-term complications.